Gross Profit (TTM) Chart

Historical Gross Profit (TTM) Data

View and export this data back to 2018. Start Trial.
Date Value
June 30, 2026 -0.3717M
March 31, 2026 -0.3686M
December 31, 2025 -0.3613M
September 30, 2025 -0.4169M
June 30, 2025 -0.4994M
March 31, 2025 -0.5789M
December 31, 2024 -0.6669M
September 30, 2024 -0.6945M
June 30, 2024 -0.7037M
March 31, 2024 -0.7136M
December 31, 2023 -0.715M
September 30, 2023 -0.6057M
June 30, 2023 -0.6631M
March 31, 2023 -0.824M
December 31, 2022 -0.9145M
September 30, 2022 -1.211M
June 30, 2022 -1.285M
Date Value
March 31, 2022 -1.253M
December 31, 2021 -1.295M
September 30, 2021 -1.227M
June 30, 2021 -1.204M
March 31, 2021 -1.171M
December 31, 2020 -1.142M
September 30, 2020 -1.100M
June 30, 2020 -1.036M
March 31, 2020 -0.9836M
December 31, 2019 -0.916M
September 30, 2019 -0.8054M
June 30, 2019 -0.7025M
March 31, 2019 -0.5999M
December 31, 2018 -0.4932M
September 30, 2018 -0.3517M
June 30, 2018 -0.2253M
March 31, 2018 -0.103M

Gross Profit Definition

Annual, Interim and Preliminary Items - Commercial, Other Financial Companies

Read full definition.

Gross Profit (TTM) Range, Past 5 Years

View Gross Profit (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Gross Profit (TTM) Benchmarks

View Gross Profit (TTM) Benchmarks
Start Trial
Biodexa Pharmaceuticals Plc -0.1719M
Mereo BioPharma Group Plc -1.195M
BioNTech SE 1.975B
Silence Therapeutics Plc 0.0975M
Compass Pathways Plc -0.0209M